In the “Bacterial Genome Architect Project (BGD)”, a synthetic genome of E. coli will be prepared by conventional method with desired characteristics for industrial applications. Project leader is Associate Professor Yasunori AIZAWA, industrial partner is Logomix Inc., a synthetic biology startup company founded in Tokyo in 2019, based on the IP of Dr. Yasunori Aizawa.

Nikkei Biotech news release, September 10, 2020